Neuland Laboratories Q2 Results FY27: Revenue Down 12.56% to Rs 449.66 Cr, PAT Down 46.69% to Rs 51.63 Cr
- November 4, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Neuland Laboratories Q2 Results FY27 were declared on 3 November 2026 on a Consolidated basis. Revenue declined 12.56% YoY to Rs 449.66 Cr from Rs 514.27 Cr, and net profit fell 46.69% YoY to Rs 51.63 Cr from Rs 96.85 Cr. These quarterly results show lower YoY growth on every line, and the sections below cover the drivers, outlook and risks.
Neuland Laboratories Ltd (NEULANDLAB) Q2 Results FY27 announced on 3 November 2026, covering the consolidated financial performance for the July to September quarter. Neuland Laboratories Q2 Results FY27 put revenue at Rs 449.66 Cr, operating profit at Rs 97.56 Cr and PAT at Rs 51.63 Cr for the three months. The results date of 3 November 2026 is the base for each comparison below, and the YoY comparison uses the same quarter of last year.
The results analysis for Neuland Laboratories Q2 Results covers the financial highlights, the business factors named in the data, the FY27 outlook and the risks to follow. Univest keeps its results notes figure first, so the highlights table below is the natural place to start.
Click Here – Get Free Investment Predictions
Neuland Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 449.66 Cr | Rs 514.27 Cr | -12.56% YoY |
| Operating Profit | Rs 97.56 Cr | Rs 155.55 Cr | -37.28% YoY |
| Net Profit (PAT) | Rs 51.63 Cr | Rs 96.85 Cr | -46.69% YoY |
Source: company filing for Neuland Laboratories Q2 Results FY27, 3 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Neuland Laboratories Q2 Results: What Stands Out
- Revenue: Rs 449.66 Cr against Rs 514.27 Cr in the comparison quarter, a YoY decline of 12.56% or Rs 64.61 Cr in absolute terms.
- Operating profit: Rs 97.56 Cr compared with Rs 155.55 Cr a year earlier, a fall of 37.28% or Rs 57.99 Cr in absolute terms.
- Net profit: Rs 51.63 Cr compared with Rs 96.85 Cr a year earlier, a fall of 46.69% or Rs 45.22 Cr in absolute terms.
- Net profit margin: 11.5% this quarter against 18.8% in the comparison quarter, because profit fell by a wider proportion than revenue.
- Quarter headline: Neuland Laboratories Q2 Results FY27 show lower revenue, lower operating profit and lower net profit than the same quarter of last year, per the 3 November 2026 filing.
Neuland Laboratories Q2 Results FY27: Performance Analysis
Neuland Laboratories reported consolidated revenue of Rs 449.66 Cr for July to September 2026, down 12.56% YoY, operating profit of Rs 97.56 Cr, down 37.28% YoY, and net profit of Rs 51.63 Cr, down 46.69% YoY. Neuland Laboratories Q2 Results FY27 therefore record declines on all three lines, with profit falling by a wider percentage at each step down the statement.
Within Neuland Laboratories Q2 Results, revenue slipped Rs 64.61 Cr from the Rs 514.27 Cr booked a year earlier, whereas operating profit gave up Rs 57.99 Cr and net profit gave up Rs 45.22 Cr. Because profit fell faster than sales, the net profit margin narrowed from 18.8% to 11.5%, which is the central reading in these quarterly results.
Readers of Neuland Laboratories Q2 Results FY27 will watch whether YoY growth returns to revenue and whether the margin steadies, since a lower sales base combined with a thinner margin compounds the effect on profit. The return ratios in the next section give a longer view.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Return on Equity – The results analysis points to the disclosed business factor first: return on equity was 21.43% in FY26, a full-year reading that sits behind the latest quarter in Neuland Laboratories Q2 Results FY27.
Return on Capital Employed – Return on capital employed was 27.50% in FY26. Read together with the return on equity figure, it describes the full-year base from which the latest quarterly decline is measured.
Operating Profit Compression – Operating profit fell 37.28% YoY to Rs 97.56 Cr while revenue fell 12.56%. This arithmetic shows profit shrinking faster than sales, and it explains why the net profit margin narrowed in the quarterly results.
FY27 Outlook After Neuland Laboratories Q2 Results
FY27 full-year results will depend on the quarters still to be declared and on conditions disclosed for the sector. This second-quarter print, with revenue at Rs 449.66 Cr and net profit at Rs 51.63 Cr, is a single data point in the year, and the next declaration will show whether the YoY pattern continues. The Univest Screener lets readers follow each new filing.
The results analysis in Neuland Laboratories Q2 Results FY27 leaves two readings to follow in the next filing: whether revenue moves back toward the Rs 514.27 Cr level of the comparison quarter, and whether the 11.5% net profit margin recovers toward the earlier 18.8%. Those readings connect directly to the risks listed next.
Key Risks to Watch After Neuland Laboratories Q2 Results FY27
Revenue Decline
Revenue declined 12.6% YoY to Rs 449.66 Cr in the latest quarter, so the first risk is a continued dip on the sales line. Neuland Laboratories Q2 Results FY27 will be compared against this lower base when the next quarter is declared.
Net Profit Fall
Net profit fell 46.7% YoY to Rs 51.63 Cr. A profit line that has almost halved is the second risk to monitor in YoY growth terms, and it fell by a wider margin than revenue.
Narrower Net Profit Margin
Net profit margin narrowed to 11.5% from 18.8% in the comparison quarter. A thinner share of sales kept as profit is the third risk to follow, because it reduces how much each rupee of revenue contributes to earnings.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
The July to September quarterly results show consolidated revenue down 12.56% YoY to Rs 449.66 Cr and net profit down 46.69% YoY to Rs 51.63 Cr. Neuland Laboratories Q2 Results FY27 therefore record lower figures on every line, with a narrower margin. Revenue and margin steadiness are the measures to follow in coming filings. Anyone tracking Neuland Laboratories Q2 Results should consult a SEBI-registered advisor before acting on any figure here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Neuland Laboratories Q2 Results FY27
What are Neuland Laboratories Q2 Results FY27?
Ans. Neuland Laboratories Q2 Results FY27 are the consolidated quarterly results declared on 3 November 2026, showing revenue of Rs 449.66 Cr and net profit of Rs 51.63 Cr, while the Quick Answer box above lays out both comparisons.
What is the results date for Neuland Laboratories Q2 Results FY27?
Ans. The results date for Neuland Laboratories Q2 Results FY27 is 3 November 2026, covering July to September 2026, so every number in the Financial Highlights table compares that quarter with the same quarter last year.
What revenue was reported in Neuland Laboratories Q2 Results FY27?
Ans. Neuland Laboratories reported consolidated Q2 revenue of Rs 449.66 Cr, compared with Rs 514.27 Cr a year earlier, which means sales were lower, as the Performance Analysis section explains in detail.
What net profit was reported in Neuland Laboratories Q2 Results FY27?
Ans. Net profit was Rs 51.63 Cr against Rs 96.85 Cr in the same quarter last year, so profit declined more steeply than revenue, a point covered in the Key Takeaways section.
How much YoY growth did revenue show in Neuland Laboratories Q2 Results FY27?
Ans. Revenue showed a YoY change of -12.56%, moving from Rs 514.27 Cr to Rs 449.66 Cr, while net profit fell by a larger 46.69%, as the Performance Analysis section sets out.
What was operating profit in Neuland Laboratories Q2 Results?
Ans. Operating profit in Neuland Laboratories Q2 Results was Rs 97.56 Cr against Rs 155.55 Cr a year earlier, a YoY fall of 37.28%, as the Key Takeaways section lists alongside revenue and net profit.
What was the net profit margin in Neuland Laboratories Q2 Results FY27?
Ans. Net profit margin was 11.5% in the latest quarter against 18.8% in the comparison quarter, so a smaller share of sales was kept as profit, a point from the Key Risks section.
What were the return ratios in Neuland Laboratories Q2 Results FY27?
Ans. Return on equity was 21.43% and return on capital employed was 27.50% in FY26, which means the full-year base is strong, as the Key Business Factors section details.
What business factors shaped Neuland Laboratories Q2 Results FY27?
Ans. Neuland Laboratories Q2 Results FY27 were shaped by FY26 return on equity of 21.43%, return on capital employed of 27.50% and operating profit falling faster than revenue, as the Key Business Factors section details.
What are the key risks after Neuland Laboratories Q2 Results FY27?
Ans. The key risks are the 12.6% revenue decline, the 46.7% net profit fall and the narrower margin of 11.5%, which the Key Risks section explains one by one.
What is the outlook after Neuland Laboratories Q2 Results?
Ans. Neuland Laboratories Q2 Results point to FY27 full-year results depending on quarters still to be declared, so the next filing will show whether revenue and net profit recover, as the Outlook section describes.
Where can I find the complete Neuland Laboratories Q2 Results FY27 data?
Ans. The complete Neuland Laboratories Q2 Results FY27 data sits in the Financial Highlights table above, which lists this quarter, the same quarter last year and the YoY change, while the Univest app offers more results tracking.
